References
- P. J. Barnes, S. D. Shapiro and R. A. Pauwels, Chronic obstructive pulmonary disease: Molecular and cellular mechanisms, Eur. Respir. J. 22 (2003) 672–688; https://doi.org/10.1183/09031936.03.00040703
- M. R. Spitz, J. E. Muscat, G. Rennert and K. K. Aben, Risk of lung cancer in family history 48 (2013) 1957–1968; https://doi.org/10.1016/j.ejca.2012.01.038
- R. Pauwels, S. Buist, P. Calverley, C. Jenkins and S. Hurd, Global strategy for the diagnosis, management and prevention of Chronic Obstructive Pulmonary Disease. NHBLI/WHO global initiative for Chronic Obstructive Lung Disease (GOLD) workshop summary, Rev. Port. Pneumol. 7 (2001) 398–400; https://doi.org/10.1016/S0873-2159(15)30846-1
- P. J. Barnes, Cellular and molecular mechanisms of chronic obstructive pulmonary disease, Clin. Chest Med. 35 (2014) 71–86; https://doi.org/10.1016/j.ccm.2013.10.004
- K. M. Beeh, O. Kornmann, R. Buhl, S. V. Culpitt, M. A. Giembycz and P. J. Barnes, Neutrophil chemotactic activity of sputum from patients with COPD, Chest 123 (2003) 1240–1247; https://doi.org/10.1378/chest.123.4.1240
- Y. Qiu, J. Zhu, V. Bandi, R. L. Atmar, K. Hattotuwa, K. K. Guntupalli and P. K. Jeffery, Biopsy neutrophilia, neutrophil chemokine and receptor gene expression in severe exacerbations of chronic obstructive pulmonary disease, Am. J. Respir. Crit. Care Med. 168 (2003) 968–975; https://doi.org/10.1164/rccm.200208-794OC
- R. E. K. Russell, A. Thorley, S. V. Culpitt, S. Dodd, L. E. Donnelly, C. Demattos, M. Fitzgerald and P. J. Barnes, Alveolar macrophage-mediated elastolysis: Roles of matrix metalloproteinases, cysteine, and serine proteases, Am. J. Physiol. - Lung Cell. Mol. Physiol. 283 (2002) 867–873; https://doi.org/10.1152/ajplung.00020.2002
- G. Caramori, M. Romagnoli, P. Casolari, C. Bellettato, G. Casoni, P. Boschetto, K. Fan Chung, P. J. Barnes, I. M. Adcock, A. Ciaccia, L. M. Fabbri and A. Papi, Nuclear localisation of p65 in sputum macrophages but not in sputum neutrophils during COPD exacerbations, Thorax 58 (2003) 348–351; https://doi.org/10.1136/thorax.58.4.348
- J. Wang, R. A. Urbanowicz, P. J. Tighe, I. Todd, J. M. Corne and L. C. Fairclough, Differential activation of killer cells in the circulation and the lung: a study of current smoking status and chronic obstructive pulmonary disease (COPD), PLoS One 8 (2013) 1–9; https://doi.org/10.1371/journal.pone.0058556
- K. F. Chung and I. M. Adcock, Multifaceted mechanisms in COPD: Inflammation, immunity, and tissue repair and destruction, Eur. Respir. J. 31 (2008) 1334–1356; https://doi.org/10.1183/09031936.00018908
- M. Williams, I. Todd and L. C. Fairclough, The role of CD8 + T lymphocytes in chronic obstructive pulmonary disease: a systematic review, Inflamm. Res. 70 (2021) 11–18; https://doi.org/10.1007/s00011-020-01408-z
- C. M. Freeman, J. L. Curtis and S. W. Chensue, CC chemokine receptor 5 and CXC chemokine receptor 6 expression by lung CD8+ cells correlates with chronic obstructive pulmonary disease severity, Am. J. Pathol. 171 (2007) 767–776; https://doi.org/10.2353/ajpath.2007.061177
- G. Chrysofakis, N. Tzanakis, D. Kyriakoy, M. Tsoumakidou, I. Tsiligianni, M. Klimathianaki and N. M. Siafakas, Perforin expression and cytotoxic activity of sputum CD8+ lymphocytes in patients with COPD, Chest 125 (2004) 71–76; https://doi.org/10.1378/chest.125.1.71
- W. C. S. Cho, C. K. Kwan, S. Yau, P. P. F. So, P. C. M. Poon and J. S. K. Au, The role of inflammation in the pathogenesis of lung cancer, Expert Opin. Ther. Targets 15 (2011) 1127–1137; https://doi.org/10.1517/14728222.2011.599801
- S. Zienolddiny, D. Campa, H. Lind, D. Ryberg, V. Skaug, L. Stangeland, D. H. Phillips, F. Canzian and A. Haugen, Polymorphisms of DNA repair genes and risk of non-small cell lung cancer, Carcinogenesis 27 (2006) 560–567; https://doi.org/10.1093/carcin/bgi232
- W. Zhou, G. Liu, D. P. Miller, S. W. Thurston, L. L. Xu, J. C. Wain, T. J. Lynch, L. Su and D. C. Chris-tiani, Polymorphisms in the DNA repair genes XRCC1 and ERCC2, smoking, and lung cancer risk, Cancer Epidemiol. Biomarkers Prev. 12 (2003) 359–365.
- P. J. Barnes, The cytokine network in chronic obstructive pulmonary disease, Am. J. Respir. Cell Mol. Biol. 41 (2009) 631–638; https://doi.org/10.1165/rcmb.2009-0220TR
- B. S. A. Silva, F. S. Lira, D. Ramos, J. S. Uzeloto, F. E. Rossi, A. P. C. F. Freire, R. N. Silva, I. B. Trevisan, L. A. Gobbo and E. M. C. Ramos, Severity of COPD and its relationship with IL-10, Cytokine 106 (2018) 95–100; https://doi.org/10.1016/j.cyto.2017.10.018
- B. R. Celli, N. Locantore, J. Yates, R. Tal-Singer, B. E. Miller, P. Bakke, P. Calverley, H. Coxson, C. Crim, L. D. Edwards, D. A. Lomas, A. Duvoix, W. MacNee, S. Rennard, E. Silverman, J. Vestbo, E. Wouters and A. Agustí, Inflammatory biomarkers improve clinical prediction of mortality in chronic obstructive pulmonary disease, Am. J. Respir. Crit. Care Med. 185 (2012) 1065–1072; https://doi.org/10.1164/rccm.201110-1792OC
- Y. Wu and B. P. Zhou, TNF-α/NF-κB/Snail pathway in cancer cell migration and invasion, Br. J. Cancer 102 (2010) 639–644; https://doi.org/10.1038/sj.bjc.6605530
- K. Gong, G. Guo, N. Beckley, Y. Zhang, X. Yang, M. Sharma and A. A. Habib, Tumor necrosis factor in lung cancer: Complex roles in biology and resistance to treatment, Neoplasia 23 (2021) 189–196; https://doi.org/10.1016/j.neo.2020.12.006
- M. H. Wang, H. J. Cordell and K. Van Steen, Statistical methods for genome-wide association studies, Semin. Cancer Biol. 55 (2019) 53–60; https://doi.org/10.1016/j.semcancer.2018.04.008
- J. N. Hirschhorn and M. J. Daly, Genome-wide association studies for common diseases and complex traits, Nat. Rev. Genet. 6 (2005) 95–108; https://doi.org/10.1038/nrg1521
- A. Sud, B. Kinnersley and R. S. Houlston, Genome-wide association studies of cancer: Current insights and future perspectives, Nat. Rev. Cancer 17 (2017) 692–704; https://doi.org/10.1038/nrc.2017.82
- Y. Bossé and C. I. Amos, A decade of GWAS results in lung cancer, Cancer Epidemiol. Biomarkers Prev. 27 (2018) 363–379; https://doi.org/10.1158/1055-9965.EPI-16-0794
- M. S. Shiels, E. A. Engels, J. Shi, M. T. Landi, D. Albanes, N. Chatterjee, S. J. Chanock, N. E. Caporaso and A. K. Chaturvedi, Genetic variation in innate immunity and inflammation pathways associated with lung cancer risk, Cancer 118 (2012) 5630–5636; https://doi.org/10.1002/cncr.27605
- Q. Wang, J. Gu, L. Wang, D. W. Chang, Y. Ye, M. Huang, J. A. Roth and X. Wu, Genetic associations of T cell cancer immune response-related genes with T cell phenotypes and clinical outcomes of early-stage lung cancer, J. Immunother. Cancer 8 (2020) Article ID e000336; (13 pages); https://doi.org/10.1136/jitc-2019-000336
- D. Watza, C. M. Lusk, G. Dyson, K. S. Purrington, A. S. Wenzlaff, C. Neslund-Dudas, A. O. Soubani, S. M. Gadgeel and A. G. Schwartz, COPD-dependent effects of genetic variation in key inflammation pathway genes on lung cancer risk, Int. J. Cancer 147 (2020) 747–756; https://doi.org/10.1002/ijc.32780
- J. Chen, R. Y. Liu, L. Yang, J. Zhao, X. Zhao, D. Lu, N. Yi, B. Han, X. F. Chen, K. Zhang, J. He, Z. Lei, Y. Zhou, B. Pasche, X. Li and H. T. Zhang, A two-SNP IL-6 promoter haplotype is associated with increased lung cancer risk, J. Cancer Res. Clin. Oncol. 139 (2013) 231–242; https://doi.org/10.1007/s00432-012-1314-z
- I. A. Yang, J. W. Holloway and K. M. Fong, Genetic susceptibility to lung cancer and co-morbidities, J. Thorac. Dis. 5(Supl. 5) (2013) S454–S462; https://doi.org/10.3978/j.issn.2072-1439.2013.08.06
- C. Sudlow, J. Gallacher, N. Allen, V. Beral, P. Burton, J. Danesh, P. Downey, P. Elliott, J. Green, M. Landray, B. Liu, P. Matthews, G. Ong, J. Pell, A. Silman, A. Young, T. Sprosen, T. Peakman and R. Collins, UK biobank: An open access resource for identifying the causes of a wide range of complex diseases of middle and old age, PLoS Med. 12 (2015) 1–10; https://doi.org/10.1371/journal.pmed.1001779
- S. A. Miller, D. D. Dykes and H. F. Polesky, A simple salting out procedure for extracting DNA from human nucleated cells, Nucleic Acids Res. 16(3) (1988) Article ID 1215 (1 page); https://doi.org/10.1093/nar/16.3.1215
- D. C. Rio, M. Ares, G. J. Hannon and T. W. Nilsen, Purification of RNA using TRIzol (TRI Reagent), Cold Spring Harb. Protoc. 5 (2010) 1–4; https://doi.org/10.1101/pdb.prot5439
- K. J. Livak and T. D. Schmittgen, Analysis of relative gene expression data using real-time quantitative PCR and the 2-ΔΔCT method, Methods 25 (2001) 402–408; https://doi.org/10.1006/meth.2001.1262
- H. Arora, S. M. Wilcox, L. A. Johnson, L. Munro, B. A. Eyford, C. G. Pfeifer, I. Welch and W. A. Jefferies, The ATP-binding cassette gene ABCF1 functions as an E2 ubiquitin-conjugating enzyme controlling macrophage polarization to dampen lethal septic shock, Immunity 50(2) (2019) Article ID e6, 418–431; https://doi.org/10.1016/j.immuni.2019.01.014
- Q. T. Cao, J. A. Aguiar, B. J. M. Tremblay, N. Abbas, N. Tiessen, S. Revill, N. Makhdami, A. Ayoub, G. Cox, K. Ask, A. C. Doxey and J. A. Hirota, ABCF1 regulates dsDNA-induced immune responses in human airway epithelial cells, Front. Cell. Infect. Microbiol. 10 (2020) 1–17; https://doi.org/10.3389/fcimb.2020.00487
- V. Zachariou, R. S. Duman and E. J. Nestler, G proteins, Basic Neurochem. (2012) 411–422; https://doi.org/10.1016/B978-0-12-374947-5.00021-3
- C. C. Fraser, G protein-coupled receptor connectivity to NF-κB in inflammation and cancer, Int. Rev. Immunol. 27 (2008) 320–350; https://doi.org/10.1080/08830180802262765
- F. Bazzoni and B. Beutler, The tumor necrosis factor ligand and receptor families, N. Engl. J. Med. 334 (1996) 1717–1725.
- M. M. Stankovic, A. R. Nestrovic, A. M. Tomovic, N. D. Petrovic-Stanojevic, M. S. Andjelic-Jelic, V. B. Dopudja-Pantic, L. M. Nagorni-Obradovic, M. M. Mitic-Milikic and D. P. Radojkovic, TNF-α-308 promotor polymorphism in patients with chronic obstructive pulmonary disease and lung cancer, Neoplasma 56 (2009) 348–352; https://doi.org/10.4149/neo_2009_04_348
- C. M. Shih, Y. L. Lee, H. L. Chiou, W. Chen, G. C. Chang, M. C. Chou and L. Y. Lin, Association of TNF-α polymorphism with susceptibility to and severity of non-small cell lung cancer, Lung Cancer 52 (2006) 15–20; https://doi.org/10.1016/j.lungcan.2005.11.011
- C. A. van der Weyden, S. A. Pileri, A. L. Feldman, J. Whisstock and H. M. Prince, Understanding CD30 biology and therapeutic targeting: a historical perspective providing insight into future directions, Blood Cancer J. 7 (2017) Article ID e603 (10 pages); https://doi.org/10.1038/bcj.2017.85
- J. S. Brody and A. Spira, Chronic obstructive pulmonary disease, inflammation, and lung cancer, Proc. Am. Thorac. Soc. 3 (2006) 535–537; https://doi.org/10.1513/pats.200603-089MS
- T. Liu, L. Zhang, D. Joo and S. C. Sun, NF-κB signaling in inflammation, Signal Transduct. Target. Ther. 2 (2017) Article ID 17023 (9 pages); https://doi.org/10.1038/sigtrans.2017.23
- J. Wang, R. Ferreira, W. Lu, S. Farrow, K. Downes, L. Jermutus, R. Minter, R. S. Al-Lamki, J. S. Pober and J. R. Bradley, TNFR2 ligation in human T regulatory cells enhances IL2-induced cell proliferation through the non-canonical NF-κB pathway, Sci. Rep. 8 (2018) 1–11; https://doi.org/10.1038/s41598-018-30621-4
- T. C. Cheung, M. W. Steinberg, L. M. Oborne, M. G. Macauley, S. Fukuyama, H. Sanjo, C. D’Souza, P. S. Norris, K. Pfeffer, K. M. Murphy, M. Kronenberg, P. G. Spear and C. F. Ware, Unconventional ligand activation of herpesvirus entry mediator signals cell survival, Proc. Natl. Acad. Sci. U. S. A. 106 (2009) 6244–6249; https://doi.org/10.1073/pnas.0902115106
- D. S. Vinay and B. S. Kwon, 4-1BB signaling beyond T cells, Cell. Mol. Immunol. 8 (2011) 281–284; https://doi.org/10.1038/cmi.2010.82
- C. Z. Ni, K. Welsh, E. Leo, C. K. Chiou, H. Wu, J. C. Reed and K. R. Ely, Molecular basis for CD40 signaling mediated by TRAF3, Proc. Natl. Acad. Sci. U. S. A. 97 (2000) 10395–10399; https://doi.org/10.1073/pnas.97.19.10395
- P. Bista, W. Zeng, S. Ryan, V. Bailly, J. L. Browning and M. E. Lukashev, TRAF3 controls activation of the canonical and alternative NFκB by the lymphotoxin beta receptor, J. Biol. Chem. 285 (2010) 12971–12978; https://doi.org/10.1074/jbc.M109.076091
- A. Oeckinghaus and S. Ghosh, The NF-kappaB family of transcription factors and its regulation., Cold Spring Harb. Perspect. Biol. 1 (2009) 1–14; https://doi.org/10.1101/cshperspect.a000034
- R. Zaynagetdinov, T. P. Sherrill, L. A. Gleaves, P. Hunt, W. Han, A. G. McLoed, J. A. Saxon, H. Tanjore, P. M. Gulleman, L. R. Young and T. S. Blackwell, Chronic NF-κB activation links COPD and lung cancer through generation of an immunosuppressive microenvironment in the lungs, Onco-target 7 (2016) 5470–5482; https://doi.org/10.18632/oncotarget.6562
- T. R. Malek and I. Castro, Interleukin-2 receptor signaling: At the interface between tolerance and immunity, Immunity 33 (2010) 153–165; https://doi.org/10.1016/j.immuni.2010.08.004
- M. Permanyer, B. Bošnjak, S. Glage, M. Friedrichsen, S. Floess, J. Huehn, G. E. Patzer, I. Odak, N. Eckert, R. Zargari, L. Ospina-Quintero, H. Georgiev and R. Förster, Efficient IL-2R signaling differentially affects the stability, function, and composition of the regulatory T-cell pool, Cell. Mol. Immunol. 18 (2021) 398–414; https://doi.org/10.1038/s41423-020-00599-z
- F. Herr, R. Lemoine, F. Gouilleux, D. Meley, I. Kazma, A. Heraud, F. Velge-Roussel, C. Baron and Y. Lebranchu, IL-2 phosphorylates STAT5 to drive IFN-γ production and activation of human dendritic cells, J. Immunol. 192 (2014) 5660–5670; https://doi.org/10.4049/jimmunol.1300422
- A. L. McDoniels-Silvers, G. D. Stoner, R. A. Lubet and M. You, Differential expression of critical cellular genes in human lung adenocarcinomas and squamous cell carcinomas in comparison to normal lung tissues, Neoplasia 4 (2002) 141–150; https://doi.org/10.1038/sj/neo/7900217
- Z. Jia, Z. Zhang, Q. Yang, C. Deng, D. Li and L. Ren, Effect of IL2RA and IL2RB gene polymorphisms on lung cancer risk, Int. Immunopharmacol. 74 (2019) Article ID 105716; https://doi.org/10.1016/j.intimp.2019.105716
- Q. Guan, Y. Tian, Z. Zhang, L. Zhang, P. Zhao and J. Li, Identification of potential key genes in the pathogenesis of chronic obstructive pulmonary disease through bioinformatics analysis, Front. Genet. 12 (2021) Article ID 754569 (11 pages); https://doi.org/10.3389/fgene.2021.754569
- H. Kato and A. Perl, Double-edged sword: Interleukin-2 promotes T regulatory cell differentiation but also expands interleukin-13- and interferon-γ-producing CD8+ T cells via STAT6-GATA-3 axis in systemic lupus erythematosus, Front. Immunol. 12 (2021) Article ID 635531 (9 pages); https://doi.org/10.3389/fimmu.2021.635531
- Y. Zhang, L. Ren, J. Sun, F. Han and X. Guo, Increased serum soluble interleukin-2 receptor associated with severity of acute exacerbation of chronic obstructive pulmonary disease, Int. J. Chron. Obstruct. Pulmon. Dis. 16 (2021) 2561–2573; https://doi.org/10.2147/COPD.S321904